Activation of the sigma receptor 1 suppresses NMDA responses in rat retinal ganglion cells

Neuroscience

Volumn 177, Issue , 2011, Pages 12-22

  Zhang, X J ^a   Liu, L L ^a   Jiang, S X ^a   Zhong, Y M ^a   Yang, X L ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

R1; G protein; Ganglion cells; Neurotransmission; NMDA receptor; Retina

Indexed keywords

1 PHENYLCYCLOHEXANECARBOXYLIC ACID 2 MORPHOLINOETHYL ESTER; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; HALOPERIDOL; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; N [2 (3,4 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; N ALLYLNORMETAZOCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL LYASE; PROTEIN KINASE C; RYANODINE RECEPTOR; SIGMA OPIATE RECEPTOR; SIGMA RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENZYME INHIBITION; INTRACELLULAR SIGNALING; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RETINA GANGLION CELL; ANIMAL; CHANNEL GATING; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; NEWBORN; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; ION CHANNEL GATING; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SIGMA; RETINAL GANGLION CELLS;

EID: 79952004386     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.12.064     Document Type: Article

References (65)

1. Akunne H.C., Zoski K.T., Whetzel S.Z., Cordon J.J., Brandon R.M., Roman F., Pugsley T.A. Neuropharmacological profile of a selective sigma ligand, igmesine: a potential antidepressant. Neuropharmacology 2001, 41:138-149.
2. Aydar E., Palmer C.P., Klyachko V.A., Jackson M.B. The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 2002, 34:399-410.
3. Baulieu E.E. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 1998, 23:963-987.
4. Bergeron R., de Montigny C., Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci 1996, 16:1193-1202.
5. Bers D.M., Patton C.W., Nuccitelli R. A practical guide to the preparation of Ca2+ buffers. Methods Cell Biol 1994, 40:3-29.
6. Buck E., Zimanyi I., Abramson J.J., Pessah I.N. Ryanodine stabilizes multiple conformational states of the skeletal muscle calcium release channel. J Biol Chem 1992, 267:23560-23567.
7. Cassano G., Gasparre G., Contino M., Niso M., Berardi F., Perrone R., Colabufo N.A. The sigma-2 receptor agonist PB28 inhibits calcium release from the endoplasmic reticulum of SK-N-SH neuroblastoma cells. Cell Calcium 2006, 40:23-28.
8. Chen L., Yang X.L. Hyperpolarization-activated cation current is involved in modulation of the excitability of rat retinal ganglion cells by dopamine. Neuroscience 2007, 150:299-308.
9. Cheng Z.X., Lan D.M., Wu P.Y., Zhu Y.H., Dong Y., Ma L., Zheng P. Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors. Exp Neurol 2008, 210:128-136.
10. Dropic A.J., Brailoiu E., Cooper R.L. Presynaptic mechanism of action induced by 5-HT in nerve terminals: possible involvement of ryanodine and IP3 sensitive Ca2+ stores. Comp Biochem Physiol A Mol Integr Physiol 2005, 142:355-361.
11. Ducibella T., Fissore R. The roles of Ca2+, downstream protein kinases, and oscillatory signaling in regulating fertilization and the activation of development. Dev Biol 2008, 315:257-279.
12. Dun Y., Thangaraju M., Prasad P., Ganapathy V., Smith S.B. Prevention of excitotoxicity in primary retinal ganglion cells by (+)-pentazocine, a sigma receptor-1 specific ligand. Invest Ophthalmol Vis Sci 2007, 48:4785-4794.
13. Fletcher E.J., Church J., Abdel-Hamid K., MacDonald J.F. Blockade by sigma site ligands of N-methyl-D-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurones. Br J Pharmacol 1995, 116:2791-2800.
14. Grishin A.A., Benquet P., Gerber U. Muscarinic receptor stimulation reduces NMDA responses in CA3 hippocampal pyramidal cells via Ca2+-dependent activation of tyrosine phosphatase. Neuropharmacology 2005, 49:328-337.
15. Gu Z., Jiang Q., Fu A.K., Ip N.Y., Yan Z. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J Neurosci 2005, 25:4974-4984.
16. Guarneri P., Cascio C., Russo D., D'Agostino S., Drago G., Galizzi G., De Leo G., Piccoli F., Guarneri M., Guarneri R. Neurosteroids in the retina: neurodegenerative and neuroprotective agents in retinal degeneration. Ann N Y Acad Sci 2003, 1007:117-128.
17. Guzman-Lenis M.S., Navarro X., Casas C. Selective sigma receptor agonist 2-(4-morpholinethyl)1-phenylcyclohexanecarboxylate (PRE084) promotes neuroprotection and neurite elongation through protein kinase C (PKC) signaling on motoneurons. Neuroscience 2009, 162:31-38.
18. Hanner M., Moebius F.F., Flandorfer A., Knaus H.G., Striessnig J., Kempner E., Glossmann H. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci U S A 1996, 93:8072-8077.
19. Hayashi T., Kagaya A., Takebayashi M., Shimizu M., Uchitomi Y., Motohashi N., Yamawaki S. Modulation by sigma ligands of intracellular free Ca2+ mobilization by N-methyl-d-aspartate in primary culture of rat frontal cortical neurons. J Pharmacol Exp Ther 1995, 275:207-214.
20. Hayashi T., Su T. The sigma receptor: evolution of the concept in neuropsychopharmacology. Curr Neuropharmacol 2005, 3:267-280.
21. Hynd M.R., Scott H.L., Dodd P.R. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 2004, 45:583-595.
22. Kalbaugh T.L., Zhang J., Diamond J.S. Coagonist release modulates NMDA receptor subtype contributions at synaptic inputs to retinal ganglion cells. J Neurosci 2009, 29:1469-1479.
23. Kekuda R., Prasad P.D., Fei Y.J., Leibach F.H., Ganapathy V. Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem Biophys Res Commun 1996, 229:553-558.
24. Kim H.W., Roh D.H., Yoon S.Y., Seo H.S., Kwon Y.B., Han H.J., Kim K.W., Beitz A.J., Lee J.H. Activation of the spinal sigma-1 receptor enhances NMDA-induced pain via PKC- and PKA-dependent phosphorylation of the NR1 subunit in mice. Br J Pharmacol 2008, 154:1125-1134.
25. Klette K.L., Lin Y., Clapp L.E., DeCoster M.A., Moreton J.E., Tortella F.C. Neuroprotective sigma ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons. Brain Res 1997, 756:231-240.
26. Kume T., Nishikawa H., Taguchi R., Hashino A., Katsuki H., Kaneko S., Minami M., Satoh M., Akaike A. Antagonism of NMDA receptors by sigma receptor ligands attenuates chemical ischemia-induced neuronal death in vitro. Eur J Pharmacol 2002, 455:91-100.
27. Liu L.L., Wang L., Zhong Y.M., Yang X.L. Expression of sigma receptor 1 mRNA and protein in rat retina. Neuroscience 2010, 167:1151-1159.
28. Lupardus P.J., Wilke R.A., Aydar E., Palmer C.P., Chen Y., Ruoho A.E., Jackson M.B. Membrane-delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G-protein nor ATP. J Physiol 2000, 526(Pt 3):527-539.
29. Margolis D.J., Detwiler P.B. Different mechanisms generate maintained activity in ON and OFF retinal ganglion cells. J Neurosci 2007, 27:5994-6005.
30. Martin P.M., Ola M.S., Agarwal N., Ganapathy V., Smith S.B. The sigma receptor ligand (+)-pentazocine prevents apoptotic retinal ganglion cell death induced in vitro by homocysteine and glutamate. Brain Res Mol Brain Res 2004, 123:66-75.
31. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 1976, 197:517-532.
32. Martina M., Turcotte M.E., Halman S., Bergeron R. The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus. J Physiol 2007, 578:143-157.
33. Masland R.H. The fundamental plan of the retina. Nat Neurosci 2001, 4:877-886.
34. Maurice T., Gregoire C., Espallergues J. Neuro(active)steroids actions at the neuromodulatory sigma1 (sigma1) receptor: biochemical and physiological evidences, consequences in neuroprotection. Pharmacol Biochem Behav 2006, 84:581-597.
35. Maurice T., Su T.P. The pharmacology of sigma-1 receptors. Pharmacol Ther 2009, 124:195-206.
36. Mayer M.L., Westbrook G.L., Guthrie P.B. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature 1984, 309:261-263.
37. Meyer D.A., Carta M., Partridge L.D., Covey D.F., Valenzuela C.F. Neurosteroids enhance spontaneous glutamate release in hippocampal neurons. Possible role of metabotropic sigma1-like receptors. J Biol Chem 2002, 277:28725-28732.
38. Monnet F.P. Sigma-1 receptor as regulator of neuronal intracellular Ca2+: clinical and therapeutic relevance. Biol Cell 2005, 97:873-883.
39. Monnet F.P., Debonnel G., Junien J.L., De Montigny C. N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. Eur J Pharmacol 1990, 179:441-445.
40. Morin-Surun M.P., Collin T., Denavit-Saubie M., Baulieu E.E., Monnet F.P. Intracellular sigma1 receptor modulates phospholipase C and protein kinase C activities in the brainstem. Proc Natl Acad Sci U S A 1999, 96:8196-8199.
41. Mtchedlishvili Z., Kapur J. A presynaptic action of the neurosteroid pregnenolone sulfate on GABAergic synaptic transmission. Mol Pharmacol 2003, 64:857-864.
42. Myers A.M., Charifson P.S., Owens C.E., Kula N.S., McPhail A.T., Baldessarini R.J., Booth R.G., Wyrick S.D. Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor. J Med Chem 1994, 37:4109-4117.
43. Ola M.S., Moore P., El-Sherbeny A., Roon P., Agarwal N., Sarthy V.P., Casellas P., Ganapathy V., Smith S.B. Expression pattern of sigma receptor 1 mRNA and protein in mammalian retina. Brain Res Mol Brain Res 2001, 95:86-95.
44. Osborne N.N., Ugarte M., Chao M., Chidlow G., Bae J.H., Wood J.P., Nash M.S. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol 1999, 43(Suppl 1):S102-S128.
45. Pang J.J., Gao F., Wu S.M. Light-evoked excitatory and inhibitory synaptic inputs to ON and OFF alpha ganglion cells in the mouse retina. J Neurosci 2003, 23:6063-6073.
46. Quirion R., Bowen W.D., Itzhak Y., Junien J.L., Musacchio J.M., Rothman R.B., Su T.P., Tam S.W., Taylor D.P. A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 1992, 13:85-86.
47. Sagdullaev B.T., McCall M.A., Lukasiewicz P.D. Presynaptic inhibition modulates spillover, creating distinct dynamic response ranges of sensory output. Neuron 2006, 50:923-935.
48. Senda T., Mita S., Kaneda K., Kikuchi M., Akaike A. Effect of SA4503, a novel sigma1 receptor agonist, against glutamate neurotoxicity in cultured rat retinal neurons. Eur J Pharmacol 1998, 342:105-111.
49. Shen Y., Liu X.L., Yang X.L. N-methyl-D-aspartate receptors in the retina. Mol Neurobiol 2006, 34:163-179.
50. Shimazu S., Katsuki H., Takenaka C., Tomita M., Kume T., Kaneko S., Akaike A. sigma receptor ligands attenuate N-methyl-D-aspartate cytotoxicity in dopaminergic neurons of mesencephalic slice cultures. Eur J Pharmacol 2000, 388:139-146.
51. Shpakov A.O., Pertseva M.N. Molecular mechanisms for the effect of mastoparan on G proteins in tissues of vertebrates and invertebrates. Bull Exp Biol Med 2006, 141:302-306.
52. Skeberdis V.A., Lan J., Opitz T., Zheng X., Bennett M.V., Zukin R.S. mGluR1-mediated potentiation of NMDA receptors involves a rise in intracellular calcium and activation of protein kinase C. Neuropharmacology 2001, 40:856-865.
53. Smith S.B. Diabetic retinopathy and the NMDA receptor. Drug News Perspect 2002, 15:226-232.
54. Smith S.B., Duplantier J., Dun Y., Mysona B., Roon P., Martin P.M., Ganapathy V. In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine. Invest Ophthalmol Vis Sci 2008, 49:4154-4161.
55. Soriani O., Foll F.L., Roman F., Monnet F.P., Vaudry H., Cazin L. A-Current down-modulated by sigma receptor in frog pituitary melanotrope cells through a G protein-dependent pathway. J Pharmacol Exp Ther 1999, 289:321-328.
56. Soriani O., Vaudry H., Mei Y.A., Roman F., Cazin L. Sigma ligands stimulate the electrical activity of frog pituitary melanotrope cells through a G-protein-dependent inhibition of potassium conductances. J Pharmacol Exp Ther 1998, 286:163-171.
57. Sucher N.J., Lipton S.A., Dreyer E.B. Molecular basis of glutamate toxicity in retinal ganglion cells. Vis Res 1997, 37:3483-3493.
58. Tchedre K.T., Huang R.Q., Dibas A., Krishnamoorthy R.R., Dillon G.H., Yorio T. Sigma-1 receptor regulation of voltage-gated calcium channels involves a direct interaction. Invest Ophthalmol Vis Sci 2008, 49:4993-5002.
59. Tchedre K.T., Yorio T. Sigma-1 receptors protect RGC-5 cells from apoptosis by regulating intracellular calcium, Bax levels, and caspase-3 activation. Invest Ophthalmol Vis Sci 2008, 49:2577-2588.
60. Ueda H., Yoshida A., Tokuyama S., Mizuno K., Maruo J., Matsuno K., Mita S. Neurosteroids stimulate G protein-coupled sigma receptors in mouse brain synaptic membrane. Neurosci Res 2001, 41:33-40.
61. Yamamoto H., Yamamoto T., Sagi N., Klenerova V., Goji K., Kawai N., Baba A., Takamori E., Moroji T. Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via sigma 1 site. J Neurosci 1995, 15:731-736.
62. Yang X.L. Characterization of receptors for glutamate and GABA in retinal neurons. Prog Neurobiol 2004, 73:127-150.
63. Zawalich W.S., Zawalich K.C. Regulation of insulin secretion by phospholipase C. Am J Physiol 1996, 271:E409-E416.
64. Zhang J., Diamond J.S. Distinct perisynaptic and synaptic localization of NMDA and AMPA receptors on ganglion cells in rat retina. J Comp Neurol 2006, 498:810-820.
65. Zhang J., Diamond J.S. Subunit- and pathway-specific localization of NMDA receptors and scaffolding proteins at ganglion cell synapses in rat retina. J Neurosci 2009, 29:4274-4286.